Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M191Revenue $M33.0Net Margin (%)-18.3Z-Score-1.8
Enterprise Value $M143EPS $-0.7Operating Margin %-21.1F-Score5
P/E(ttm))0Cash Flow Per Share $-1.2Pre-tax Margin (%)-18.2Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %0Quick Ratio1.8Cash flow > EarningsN
Price/Sales4.85-y EBITDA Growth Rate %-66.4Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-6.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-24.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M153ROI % (ttm)-164.8Gross Margin Increase y-yY

Gurus Latest Trades with ZGNX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ZGNX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ZGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GARNER CAM LDirector 2014-06-13Buy30,000$1.66-24.7view
FARR STEPHEN JPresident and COO 2014-06-03Sell20,900$2.1-40.48view
HAWLEY ROGERCEO 2014-06-03Sell25,078$2.1-40.48view
RHOADS ANN DEVP, CFO, Treasurer & Sec. 2014-06-03Sell19,229$2.1-40.48view
Shively Richard ScottChief Commercial Officer 2014-06-03Sell19,229$2.1-40.48view
Shively Richard ScottChief Commercial Officer 2013-11-20Buy67,000$2.79-55.2view
Robinson Cynthia YChief Development Officer 2012-12-13Buy50,000$1.176.84view
GARNER CAM LDirector 2012-12-12Buy70,000$1.213.31view
RHOADS ANN DEVP, CFO, Treasurer & Sec. 2012-12-12Buy17,500$1.195.04view
MAST ERLE TDirector 2012-12-11Buy10,000$1.158.7view

Press Releases about ZGNX :

    Quarterly/Annual Reports about ZGNX:

    News about ZGNX:

    Articles On GuruFocus.com
    comment on ZGNX Mar 23 2013 
    Weekly CFO Buys Highlight: NGL, UNTK, ZGNX, VTSS, RVSB Dec 24 2012 
    (ZGNX) CEO Roger Hawley buys 10,000 Shares Dec 06 2010 

    More From Other Websites
    ZOGENIX, INC. Files SEC form 8-K/A, Other Events, Financial Statements and Exhibits Dec 23 2014
    Zogenix to Participate in Oppenheimer 25th Annual Healthcare Conference Dec 03 2014
    Zogenix to Participate in Oppenheimer 25th Annual Healthcare Conference Dec 03 2014
    Results of Long-Term, Open-Label Study Published in the Journal of Pain Research Demonstrate the... Dec 01 2014
    Results of Long-Term, Open-Label Study Published in the Journal of Pain Research Demonstrate the... Dec 01 2014
    FDA approves Purdue's painkiller that can reduce abuse Nov 20 2014
    ZOGENIX, INC. Financials Nov 18 2014
    ZOGENIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 18 2014
    Zogenix to Participate in Stifel 2014 Healthcare Conference Nov 12 2014
    Zogenix to Participate in Stifel 2014 Healthcare Conference Nov 12 2014
    10-Q for Zogenix, Inc. Nov 08 2014
    Zogenix beats Street 3Q forecasts Nov 06 2014
    Zogenix beats Street 3Q forecasts Nov 06 2014
    Zogenix Inc Earnings Call scheduled for 4:30 pm ET today Nov 06 2014
    Zogenix Reports Third Quarter 2014 Financial Results Nov 06 2014
    ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 06 2014
    Zogenix Reports Third Quarter 2014 Financial Results Nov 06 2014
    Q3 2014 Zogenix Inc Earnings Release - After Market Close Nov 06 2014
    ZOGENIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement Oct 31 2014
    Zogenix and Purdue Pharma Exchange Waivers of Regulatory Exclusivity for Extended-Release... Oct 31 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK